Free Trial

Risk-Off Flows Creep In As Moderna Sound Cautious Re: Omicron

CROSS ASSET

Light defensive flows creep in on the back of an FT interview which notes that “the chief executive of Moderna predicted that existing vaccines will be much less effective at tackling Omicron than earlier strains of Covid-19 and warned it would take months before pharmaceutical companies can manufacture new variant-specific jabs at scale.” T-Notes make new session highs, trading through Monday’s peak, while oil and e-minis soften. Elsewhere, JPY moves to the top of the G10 FX leader board after struggling early on.

MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.